DocDollars

Tesaro, Inc.

MA · United States · Reporting entity ID 100000151576

Total reported 2019–2025
$88.2M
#107 of 2,960 reporting companies — 0.1% of all reported industry payments
$3.17M in general payments across 9,515 records, plus $85.1M in research funding across 4,458 records.

How it breaks down

General payments $3,167,218
Research funding $85,051,857

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Tesaro, Inc. reported $88.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #107 of 2,960 reporting companies. 96% of that was research funding and 4% general payments such as consulting, speaking, food and travel. 9,515 general payment records and 4,458 research records were filed.

Common questions about Tesaro, Inc.

How much has Tesaro, Inc. paid US doctors?

Tesaro, Inc. reported $88,219,075 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,167,218 in general payments, $85,051,857 in research funding.

How does Tesaro, Inc. rank among drug and device companies?

It ranks #107 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Tesaro, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.